These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 27902902

  • 1. History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts.
    Schat KA.
    Avian Dis; 2016 Dec; 60(4):715-724. PubMed ID: 27902902
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H, Quanz S, Suurland B, Spijkers IE, Rodenberg J, Davelaar FG, Jongsma B, Kumar M.
    Vaccine; 2008 Oct 16; 26(44):5595-600. PubMed ID: 18706949
    [Abstract] [Full Text] [Related]

  • 3. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
    Chang S, Xie Q, Dunn JR, Ernst CW, Song J, Zhang H.
    Vaccine; 2014 Apr 01; 32(16):1820-7. PubMed ID: 24530405
    [Abstract] [Full Text] [Related]

  • 4. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
    Chang S, Ding Z, Dunn JR, Lee LF, Heidari M, Song J, Ernst CW, Zhang H.
    Avian Dis; 2011 Sep 01; 55(3):384-90. PubMed ID: 22017035
    [Abstract] [Full Text] [Related]

  • 5. Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek's disease viruses.
    Gimeno IM, Dunn JR, Cortes AL, El-Gohary Ael-G, Silva RF.
    Avian Dis; 2014 Jun 01; 58(2):232-43. PubMed ID: 25055627
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of cell-associated vaccines against Marek's disease virus grown in QT35 cells or JBJ-1 cells.
    Geerligs H, Spijkers I, Rodenberg J.
    Avian Dis; 2013 Jun 01; 57(2 Suppl):448-53. PubMed ID: 23901760
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype.
    Lee LF, Bacon LD, Yoshida S, Yanagida N, Zhang HM, Witter RL.
    Avian Dis; 2004 Jun 01; 48(1):129-37. PubMed ID: 15077806
    [Abstract] [Full Text] [Related]

  • 8. Towards a mechanistic understanding of the synergistic response induced by bivalent Marek's disease vaccines to prevent lymphomas.
    Umthong S, Dunn JR, Cheng HH.
    Vaccine; 2019 Oct 08; 37(43):6397-6404. PubMed ID: 31515142
    [Abstract] [Full Text] [Related]

  • 9. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C, Nervi P, Risso M.
    Avian Pathol; 2004 Apr 08; 33(2):190-5. PubMed ID: 15276986
    [Abstract] [Full Text] [Related]

  • 10. A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek's disease virus and hinders tumor development in chickens.
    Parvizi P, Mallick AI, Haq K, Haghighi HR, Orouji S, Thanthrige-Don N, St Paul M, Brisbin JT, Read LR, Behboudi S, Sharif S.
    Viral Immunol; 2012 Oct 08; 25(5):394-401. PubMed ID: 22857262
    [Abstract] [Full Text] [Related]

  • 11. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
    Mays JK, Black-Pyrkosz A, Spatz S, Fadly AM, Dunn JR.
    Avian Pathol; 2016 Dec 08; 45(6):657-666. PubMed ID: 27258614
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.
    Zhang Y, Liu C, Yan F, Liu A, Cheng Y, Li Z, Sun G, Lv H, Wang X.
    Vaccine; 2017 Aug 24; 35(36):4695-4701. PubMed ID: 28754487
    [Abstract] [Full Text] [Related]

  • 14. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ, Smith LP, Nair VK, Currie RJ.
    Vet Immunol Immunopathol; 2006 Jul 15; 112(1-2):78-86. PubMed ID: 16682084
    [Abstract] [Full Text] [Related]

  • 15. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF, Groenendal JE, Boerrigter HM, Kok GL, Pol JM.
    Avian Dis; 1986 Jul 15; 30(2):276-83. PubMed ID: 3015113
    [Abstract] [Full Text] [Related]

  • 16. Differential amplification of Marek's disease CVI988 vaccine and of wild-type isolates from organs of commercial chickens using single or duplexed probes in real-time PCR.
    Davidson I, Natour-Altoury A, Raibstein I, Dahan Y.
    Avian Pathol; 2017 Dec 15; 46(6):610-614. PubMed ID: 28532188
    [Abstract] [Full Text] [Related]

  • 17. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
    Ralapanawe S, Walkden-Brown SW, Renz KG, Islam AF.
    Avian Pathol; 2016 Dec 15; 45(1):26-37. PubMed ID: 26503904
    [Abstract] [Full Text] [Related]

  • 18. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
    Lee LF, Kreager KS, Arango J, Paraguassu A, Beckman B, Zhang H, Fadly A, Lupiani B, Reddy SM.
    Vaccine; 2010 Feb 03; 28(5):1294-9. PubMed ID: 19941987
    [Abstract] [Full Text] [Related]

  • 19. A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.
    Conradie AM, Bertzbach LD, Bhandari N, Parcells M, Kaufer BB.
    mSphere; 2019 Oct 09; 4(5):. PubMed ID: 31597721
    [Abstract] [Full Text] [Related]

  • 20. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
    Witter RL, Kreager KS.
    Avian Dis; 2004 Dec 09; 48(4):768-82. PubMed ID: 15666858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.